The collapse of Theranos is one of the most notorious cases of misrepresentation in recent business history. Fronted by the seemingly impressive entrepreneur Elizabeth Holmes, who started the company during her freshman year at Stanford University, Theranos had attracted a valuation of $10 billion (£7.8bn) by the time Holmes was in her late 20s. But the tech behind the business, which could supposedly perform blood tests with only tiny volumes of blood, simply didn’t exist. Not only that, but Holmes was using money from the company to fund a very luxurious lifestyle including private jets, personal security and a $25,000-a-month personal publicist.
After a whistleblower exposed that the company was secretly outsourcing its tests in 2018, Holmes was charged with nine counts of wire fraud and two counts of conspiracy to commit wire fraud. Unsurprisingly, Theranos ceased trading the same year. Holmes' trial came to a close in January 2022 after the jury found her guilty of four counts of fraud, with each count carrying a maximum sentence of 20 years behind bars. Her business partner, and former boyfriend, Sunny Balwani will also go on trial later this year.